Global Diagnostic Radiopharmaceuticals Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Diagnostic Radiopharmaceuticals market size will reach 6,269.88 Million USD in 2025 and is projected to reach 10,233.88 Million USD by 2032, with a CAGR of 7.25% (2025-2032). Notably, the China Diagnostic Radiopharmaceuticals market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Diagnostic radiopharmaceuticals are specialized compounds containing a radioactive material and a pharmaceutical component that are used in nuclear medicine imaging procedures. These radiopharmaceuticals emit gamma rays, which can be detected by medical imaging devices like gamma cameras or positron emission tomography (PET) scanners. When introduced into the body, these compounds selectively accumulate in specific organs or tissues, allowing healthcare professionals to visualize physiological processes, metabolic activity, or functional abnormalities. Diagnostic radiopharmaceuticals play a crucial role in various medical imaging tests, such as bone scans, cardiac perfusion studies, and PET scans, providing valuable insights into the inner workings of the body and aiding in the diagnosis and monitoring of diseases and conditions.
The major global suppliers of Diagnostic Radiopharmaceuticals include Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, SIEMENS, Advanced Accelerator Applications, China Isotope & Radiation, Dongcheng Pharmaceutical Group, Lantheus, Eli Lilly, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Diagnostic Radiopharmaceuticals. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Diagnostic Radiopharmaceuticals market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Diagnostic Radiopharmaceuticals market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Diagnostic Radiopharmaceuticals industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Diagnostic Radiopharmaceuticals Include:
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
SIEMENS
Advanced Accelerator Applications
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Diagnostic Radiopharmaceuticals Product Segment Include:
Technetium 99
Fluorine 18
Others
Diagnostic Radiopharmaceuticals Product Application Include:
Oncology
Cardiology
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Diagnostic Radiopharmaceuticals Industry PESTEL Analysis
Chapter 3: Global Diagnostic Radiopharmaceuticals Industry Porter's Five Forces Analysis
Chapter 4: Global Diagnostic Radiopharmaceuticals Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Diagnostic Radiopharmaceuticals Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Diagnostic Radiopharmaceuticals Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Diagnostic Radiopharmaceuticals Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Diagnostic Radiopharmaceuticals market size will reach 6,269.88 Million USD in 2025 and is projected to reach 10,233.88 Million USD by 2032, with a CAGR of 7.25% (2025-2032). Notably, the China Diagnostic Radiopharmaceuticals market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Diagnostic radiopharmaceuticals are specialized compounds containing a radioactive material and a pharmaceutical component that are used in nuclear medicine imaging procedures. These radiopharmaceuticals emit gamma rays, which can be detected by medical imaging devices like gamma cameras or positron emission tomography (PET) scanners. When introduced into the body, these compounds selectively accumulate in specific organs or tissues, allowing healthcare professionals to visualize physiological processes, metabolic activity, or functional abnormalities. Diagnostic radiopharmaceuticals play a crucial role in various medical imaging tests, such as bone scans, cardiac perfusion studies, and PET scans, providing valuable insights into the inner workings of the body and aiding in the diagnosis and monitoring of diseases and conditions.
The major global suppliers of Diagnostic Radiopharmaceuticals include Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, SIEMENS, Advanced Accelerator Applications, China Isotope & Radiation, Dongcheng Pharmaceutical Group, Lantheus, Eli Lilly, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Diagnostic Radiopharmaceuticals. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Diagnostic Radiopharmaceuticals market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Diagnostic Radiopharmaceuticals market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Diagnostic Radiopharmaceuticals industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Diagnostic Radiopharmaceuticals Include:
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
SIEMENS
Advanced Accelerator Applications
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Diagnostic Radiopharmaceuticals Product Segment Include:
Technetium 99
Fluorine 18
Others
Diagnostic Radiopharmaceuticals Product Application Include:
Oncology
Cardiology
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Diagnostic Radiopharmaceuticals Industry PESTEL Analysis
Chapter 3: Global Diagnostic Radiopharmaceuticals Industry Porter's Five Forces Analysis
Chapter 4: Global Diagnostic Radiopharmaceuticals Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Diagnostic Radiopharmaceuticals Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Diagnostic Radiopharmaceuticals Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Diagnostic Radiopharmaceuticals Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Diagnostic Radiopharmaceuticals Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Diagnostic Radiopharmaceuticals Product by Type
- 1.2.1 Technetium 99
- 1.2.2 Fluorine 18
- 1.2.3 Others
- 1.3 Diagnostic Radiopharmaceuticals Product by Application
- 1.3.1 Oncology
- 1.3.2 Cardiology
- 1.3.3 Other
- 1.4 Global Diagnostic Radiopharmaceuticals Market Size Analysis (2020-2032)
- 1.5 Diagnostic Radiopharmaceuticals Market Development Status and Trends
- 1.5.1 Diagnostic Radiopharmaceuticals Industry Development Status Analysis
- 1.5.2 Diagnostic Radiopharmaceuticals Industry Development Trends Analysis
- 2 Diagnostic Radiopharmaceuticals Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Diagnostic Radiopharmaceuticals Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Diagnostic Radiopharmaceuticals Market Analysis by Country
- 4.1 Global Diagnostic Radiopharmaceuticals Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Diagnostic Radiopharmaceuticals Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.5 China Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.6 France Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.14 India Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Diagnostic Radiopharmaceuticals Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Diagnostic Radiopharmaceuticals Market Revenue by Key Suppliers (2021-2025)
- 5.2 Diagnostic Radiopharmaceuticals Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Diagnostic Radiopharmaceuticals Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Diagnostic Radiopharmaceuticals Market Analysis by Type
- 6.1 Global Diagnostic Radiopharmaceuticals Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Diagnostic Radiopharmaceuticals Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Cardinal Health
- 7.1.1 Cardinal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
- 7.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 GE Healthcare
- 7.2.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
- 7.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Curium Pharma
- 7.3.1 Curium Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
- 7.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Jubilant Pharma
- 7.4.1 Jubilant Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
- 7.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Bracco Imaging
- 7.5.1 Bracco Imaging Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
- 7.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 SIEMENS
- 7.6.1 SIEMENS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
- 7.6.3 SIEMENS Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Advanced Accelerator Applications
- 7.7.1 Advanced Accelerator Applications Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
- 7.7.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 China Isotope & Radiation
- 7.8.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
- 7.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Dongcheng Pharmaceutical Group
- 7.9.1 Dongcheng Pharmaceutical Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
- 7.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Lantheus
- 7.10.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
- 7.10.3 Lantheus Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Eli Lilly
- 7.11.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
- 7.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
- 8.2 Diagnostic Radiopharmaceuticals Product Downstream Application Analysis
- 8.2.1 Global Diagnostic Radiopharmaceuticals Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Diagnostic Radiopharmaceuticals Revenue and Forecast by Application (2020-2032)
- 8.3 Diagnostic Radiopharmaceuticals Typical Downstream Customers
- 8.4 Diagnostic Radiopharmaceuticals Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
